Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026

Go back to Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026
(NASDAQ: SYRE) Delayed: 93.12 +1.72 (1.88%)
Previous Close $91.40    52 Week High $ 
Open $92.78    52 Week Low $ 
Day High $95.17    P/E N/A 
Day Low $92.32    EPS $ 
Volume 475,993